You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Microvesicles derived from human Wharton’s Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1
|
---|---|
Published in |
Stem Cell Research & Therapy, March 2014
|
DOI | 10.1186/scrt428 |
Pubmed ID | |
Authors |
Xiangyu Zou, Guangyuan Zhang, Zhongliang Cheng, Deming Yin, Tao Du, Guanqun Ju, Shuai Miao, Guohua Liu, Mujun Lu, Yingjian Zhu |
Abstract |
Studies have demonstrated that mesenchymal stromal cells (MSCs) could reverse acute and chronic kidney injury by a paracrine or endocrine mechanism, and microvesicles (MVs) have been regarded as a crucial means of intercellular communication. In the current study, we focused on the therapeutic effects of human Wharton-Jelly MSCs derived microvesicles (hWJMSC-MVs) in renal ischemia-reperfusion injury and its potential mechanisms. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 140 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 1% |
United States | 1 | <1% |
Unknown | 137 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 26 | 19% |
Researcher | 19 | 14% |
Student > Master | 18 | 13% |
Student > Bachelor | 17 | 12% |
Student > Doctoral Student | 7 | 5% |
Other | 21 | 15% |
Unknown | 32 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 29 | 21% |
Biochemistry, Genetics and Molecular Biology | 27 | 19% |
Agricultural and Biological Sciences | 13 | 9% |
Engineering | 7 | 5% |
Neuroscience | 5 | 4% |
Other | 13 | 9% |
Unknown | 46 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 May 2015.
All research outputs
#14,777,143
of 22,749,166 outputs
Outputs from Stem Cell Research & Therapy
#1,198
of 2,414 outputs
Outputs of similar age
#126,232
of 223,385 outputs
Outputs of similar age from Stem Cell Research & Therapy
#22
of 29 outputs
Altmetric has tracked 22,749,166 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,414 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 223,385 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.